1. Galasko CS. Skeletal metastases. Clin Orthop Relat Res. 1986;210:18–30.
2. Even-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Leibovitch I. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. J Nucl Med. 2006;47:287–97.
3. Schirrmeister H, Glatting G, Hetzel J, Nussle K, Arslandemir C, Buck AK, et al. Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer. J Nucl Med. 2001;42:1800–4.
4. Gratz S, Becker W. Nuclear medicine study potentials in diseases of the skeletal system. Radiologe. 2000;40:953–62.
5. Gratz S, Höffken H, Kaiser W, Klose KJ, Behr TM. Is there still enough diagnostic confidence with bone SPECT scintigraphy alone: a retrospective evaluation and extended review of the literature. Open Med Imag J. 2008;2:7–13.